Elias A. Castilla

Papers

Total Citations

H-Index

About

Elias A. Castilla is a pioneering figure in the field of interventional oncology and image-guided therapies, with a primary focus on the development and clinical translation of non-invasive ablation technologies. His most-cited work, "Initial evaluation of cyberknife technology for extracorporeal renal tissue ablation" (2003, 76 citations), represents a landmark contribution that demonstrated the feasibility of using robotic radiosurgery for precise, non-invasive treatment of renal tumors. This study laid crucial groundwork for expanding stereotactic body radiation therapy (SBRT) beyond cranial applications, directly influencing the evolution of modern cancer care. Castilla’s research bridges engineering innovation and clinical practice, addressing critical challenges in tumor targeting, dose delivery, and organ preservation. His work has been widely recognized for its translational impact, earning over 75 citations and serving as a foundational reference for subsequent clinical trials and technological refinements. By validating cyberknife technology for extracorporeal applications, Castilla has helped establish a new paradigm in minimally invasive oncology, offering patients viable alternatives to surgery. His contributions continue to inspire researchers and clinicians seeking to advance precision medicine in cancer treatment.